Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001984861 | SCV002211015 | uncertain significance | not provided | 2024-11-05 | criteria provided, single submitter | clinical testing | This sequence change affects a donor splice site in intron 8 of the IFNAR2 gene. While this variant is not anticipated to result in nonsense mediated decay, it likely alters RNA splicing and results in a disrupted protein product. This variant is present in population databases (rs746775306, gnomAD 0.001%). This variant has not been reported in the literature in individuals affected with IFNAR2-related conditions. ClinVar contains an entry for this variant (Variation ID: 1435309). Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Laboratorio de Genetica e Diagnostico Molecular, |
RCV002243487 | SCV002512262 | uncertain significance | Immunodeficiency 45 | 2022-02-17 | criteria provided, single submitter | clinical testing | ACMG classification criteria: PVS1 moderate, PM2 moderate |